When you use our sites, PAREXEL will assign cookie files (“Cookies”) to you, which are a small amount of information we send to your web browser. Cookies enable the computers operating our websites to differentiate between visitors and to track the patterns of activities engaged in by different visitors. By clicking the Continue Browsing button or continuing to use this site, you agree to accept the PAREXEL Privacy Policy and all Cookies deployed on this site. You may choose to continue browsing with cookies, or leave the site.

Skip to main content

Solutions
Expertise
Company
Trials

China
Japan

Solutions
Expertise
Company
Trials

Contact Us

China
Japan

Solutions
Innovations & Therapeutic Expertise
Volunteers, Studies & Investigators
Ecosystem, Education & Careers
News, Events & Resources
About Us
Careers

Solutions
Expertise
Patient Stories
Trials
Resources
News & Events
COVID-19
Company
Careers

China
Japan

Contact Us

Get Personalized Email Content

Global Locations

275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300

2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170

Solutions Overview
Clinical Development
Outsourcing Services

Parexel^® Biotech
Consulting
Medical Affairs
Real-World Evidence and Late Phase

Solutions by Industry
- Pharma Solutions
- Medical Devices
Solutions by Development Phase

Overview
Patient Centricity
Precision Medicine
Adaptive & Flexible Trials
Real World Evidence
The Innovation Imperative
Our Experts

Therapeutic Areas

Overview
T.J.'s Story
Tina's Story
Dayson & Erika's Story
Paul's Story
Monica's Story

Rob's Story
Yasmeem's Story
Anisha's Story
Sara's Story
Stacy's Story

Trial Volunteer Overview
Investigators
- Clinical Trial Investigator Sign-Up

Global Study Locations

Parexel Resource Center
Parexel Insights Blog
Podcasts
Drug Innovation
Our Experts
Parexel Academy
Your Preferences

Social Channels
- LinkedIn
- Facebook
- Twitter
- YouTube

Parexel Newsroom
Events and Webinars

Long COVID Syndrome Program
COVID-19 Response

COVID-19 Resource Center
COVID Clearinghouse Data Platform

Our Company
Leadership Team
Our DE&I Strategy
- Discussions in Diversity
Suppliers
Career Opportunities
- Find Your Career Path
Trust & Privacy
Environmental, Social, & Governance (ESG)
External Support Center

Compliance & Ethics
Global Locations
Partners
Contact Us

Career Opportunities
- Find Your Career Path

Regulatory & Access Resources

Browse our regulatory & access resources to find the latest articles, blogs, brochures, and videos from our experts. See the latest content below.

Home
COVID-19
Latest Content
Meet our experts
About us

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Articles & Whitepapers
Communicating Value to Providers and Payers

Communicating Value to Providers and Payers

Fill form to unlock content

Loading, please wait

Error - something went wrong!

Register now for full access to all the content

Thank you for registering!

Download PDF

No Previous Flipbooks
Next Flipbook

Early planning can help you make the most of expedited regulatory pathways

Other content in this Stream

Early planning can help you make the most of expedited regulatory pathways

View Now
How biotechs can strengthen their value story with advanced analytics

Read five ways biotech companies can enhance their value story with advanced analytics.

View Now
New endpoints for early-stage cancer are gaining regulatory traction

View Now
How emerging biotechs can enter the Chinese market and prosper

In this article, Parexel experts outline five approaches that foreign companies with limited resources should use to gain a foothold in the Chinese market.

View Now
Making Expedited Regulatory Pathways Work for Global Drug Development Programs

Article from December 2021 edition of Applied Clinical Trials. Parexel regulatory experts offer top tips for working with regulators on a global scale.

View Now
What to know about FDA INTERACT meetings

Our regulatory expert and former FDA regulator Steve Winitsky shares his advice on planning and preparing for an effective INTERACT meeting.

View Now
Decentralized trial tools and technologies are here to stay: A regulatory perspective

COVID-19 led to an era of remarkable regulatory flexibility and innovation with Decentralized Clinical Trial (DCT) strategies and tools but are they here to stay? Read more in this article.

View Now
Maximize the efficiency of regulatory operations with five key competencies

In this article, Parexel regulatory outsourcing experts explore five competencies, companies can use to manage post-marketing regulatory requirements better and more efficiently.

View Now
Maximize the efficiency of regulatory operations with five key competencies

In this article, Parexel regulatory outsourcing experts explore five competencies companies can use to manage post-marketing regulatory requirements better and more efficiently.

View Now
Lessons from China and the United States on the use of RWE in regulatory submissions

View Now
Can Synthetic / External Control Arms meet regulatory and HTA requirements?

This article summarizes a recent panel discussion where experts from Parexel and biotech company, MorphoSys, shared their experiences from recent pioneering efforts in RWE.

View Now
Strategies for External Control Arms

View Now
Impending avalanche of regulatory compliance activity: Are you prepared?

View Now
Crafting an early genomics strategy in oncology drug development

Discover three key considerations for crafting a successful genomic biomarker strategy in this article.

View Now
Preparing for EU-CTR

View Now
Five competencies for operational excellence in cell and gene therapy clinical trials

What is different about cell & gene therapy trials, and what does it take to operationalize them effectively? We break it down into five competencies you need for success.

View Now
Whitepaper: COVID-19 Vaccination in Cancer Patients

In this whitepaper, we address the unique variables, optimal timing, and immunogenic considerations for vaccinating individuals with cancer.

View Now
3 ways to reap the benefits of adaptive-trials

View Now
Navigating the new normal for meetings – now and for the future

View Now
Impact of Clinical Trials in Rare Disease and Oncology

View Now